#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4193780	B	Inhibition of Enterovirus 71 Shenzhen/120F1/09 capsid infected in human RD cells assessed as reduction in virus-induced cell death after 72 hrs by CCK-8 assay	Enterovirus A71	22		cell-based format	Scientific Literature
2.	ALA4193781	A	Cytotoxicity against human RD cells assessed as reduction in cell viability after 72 hrs by CCK-8 assay	Homo sapiens	16		cell-based format	Scientific Literature
3.	ALA4193783	A	Clearance in CD-1 mouse at 2 mg/kg, iv administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
4.	ALA4193784	A	Elimination half life in CD-1 mouse at 2 mg/kg, iv administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
5.	ALA4193785	A	Volume of distribution in CD-1 mouse at 2 mg/kg, iv administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
6.	ALA4193786	A	AUC in CD-1 mouse at 2 mg/kg, iv administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
7.	ALA4193787	A	Cmax in CD-1 mouse at 5 mg/kg, ip administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
8.	ALA4193788	A	Tmax in CD-1 mouse at 5 mg/kg, ip administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
9.	ALA4193789	A	AUC in CD-1 mouse at 5 mg/kg, ip administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
10.	ALA4193790	A	Oral bioavailability in CD-1 mouse at 5 mg/kg, ip administered as single dose	Mus musculus	7		organism-based format	Scientific Literature
11.	ALA4193795	B	Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay	Homo sapiens	6		cell-based format	Scientific Literature
12.	ALA4193799	F	Antiviral activity against EV71 695F infected in ICR mouse assessed as protection against viral infection by measuring mouse survival at 10 mg/kg, ip qd administered for 7 days dosed prior to viral infection measured for 2 weeks relative to control	Enterovirus A71	1		organism-based format	Scientific Literature
13.	ALA4193800	F	Antiviral activity against EV71 695F infected in ICR mouse assessed as protection against viral infection by measuring mouse survival at 10 mg/kg, ip qd administered for 7 days dosed after viral infection measured for 2 weeks relative to control	Enterovirus A71	1		organism-based format	Scientific Literature
14.	ALA4193801	F	Antiviral activity against EV71 695F infected in ICR mouse assessed as decrease in body weight loss at 10 mg/kg, ip qd administered for 7 days dosed prior to viral infection measured for 2 weeks	Enterovirus A71	1		organism-based format	Scientific Literature
15.	ALA4193802	F	Antiviral activity against EV71 695F infected in ICR mouse assessed as decrease in body weight loss at 10 mg/kg, ip qd administered for 7 days dosed after viral infection measured for 2 weeks	Enterovirus A71	1		organism-based format	Scientific Literature
16.	ALA4193803	F	Antiviral activity against EV71 695F infected in ICR mouse assessed as effect on clinical score at 10 mg/kg, ip qd administered for 7 days dosed prior to viral infection measured for 2 weeks	Enterovirus A71	1		organism-based format	Scientific Literature
17.	ALA4193804	F	Antiviral activity against EV71 695F infected in ICR mouse assessed as effect on clinical score at 10 mg/kg, ip qd administered for 7 days dosed after viral infection measured for 2 weeks	Enterovirus A71	1		organism-based format	Scientific Literature